Palantir's AI Dominance Tested by Rival Threat and Valuation Fears

A social media post from a prominent short-seller has ignited a fierce debate over Palantir Technologies' future, sending its shares into a tailspin and exposing deep investor anxiety over its premium valuation. The stock plummeted roughly 17% over four trading sessions following comments from Michael Burry of Scion Capital, who questioned whether AI startup Anthropic could render Palantir's core business obsolete.

Burry's argument hinges on a stark comparison of growth trajectories. He noted that Anthropic reportedly scaled its annual recurring revenue from $9 billion to $30 billion in just months, a feat that contrasts sharply with Palantir's two-decade journey to reach $5 billion in annual revenue. The deeper concern for investors is Anthropic's new "Managed Agents" suite of autonomous AI systems, which could potentially bypass the very integration layer upon which Palantir's platform business is built.

This sell-off occurred despite a week of ostensibly positive news for the data analytics firm. Former President Donald Trump praised Palantir's "outstanding war capabilities" on Truth Social, and the company's foundational Maven Smart System AI is now an officially recognized program within the U.S. Department of Defense. That classification ensures long-term budget security, complementing an existing U.S. Army framework contract that allows for procurements of up to $10 billion over a decade.

The market's reaction highlights a glaring disconnect between Palantir's strong operational narrative and its stock price performance. Even with the recent decline, the share price of 108.84 euros sits nearly 24% below where it started the year and far from its November 2025 all-time high. Trading volume last Friday spiked to 115 million shares, more than double the three-month average, signaling intense selling pressure was not incidental noise.

Should investors sell immediately? Or is it worth buying Palantir?

At the heart of the turmoil is Palantir's rich valuation, which remains a primary point of contention. The stock trades at approximately 109 times its expected 2026 earnings and 47 times expected sales, ranking it among the most expensive names in the S&P 500. Burry revealed he has been short the stock since last fall, calling it massively overvalued even after its pullback from $200. In sharp dissent, Wedbush analyst Dan Ives argued this critique ignores Palantir's proprietary Ontology framework, its expanding commercial customer base, and its deep government integration.

The company's recent financial performance tells a story of explosive growth, particularly in its commercial segment. U.S. commercial revenue surged 109% in 2025 to $1.5 billion. In the fourth quarter of 2025 alone, total revenue hit $1.41 billion, a 70% year-over-year increase, with U.S. commercial sales jumping 137% to $507 million. Management has set an ambitious target for 2026, forecasting revenue between $7.18 billion and $7.2 billion, which would represent growth of about 61%.

All eyes now turn to Palantir's upcoming quarterly report, expected on May 11, 2026, as the next critical test. The company has guided for first-quarter revenue between $1.532 billion and $1.536 billion, with operating income targeted between $870 million and $874 million. Analysts are anticipating earnings per share of $0.29. Palantir has a strong track record of exceeding profit expectations, beating consensus EPS by an average of 15% over the past six quarters.

Palantir at a turning point? This analysis reveals what investors need to know now.

Whether the company can once again surpass forecasts and, more importantly, assuage fears about competitive threats from players like Anthropic will likely determine if this period of weakness is remembered as a buying opportunity or the precursor to a deeper correction.

Ad

Palantir Stock: New Analysis - 12 April

Fresh Palantir information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Palantir analysis...

en | US69608A1088 | PALANTIRS | boerse | 69131762 |